연구성과로 돌아가기

2024 연구자 정보 (416 / 1079)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 교신저자 여부 Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Oh, Jaeyoung
(Oh, J)
제1저자 Kyungpook Natl Univ, Dept Mat Sci & Met Engn, Daegu 41566, South Korea

[JCR상위 16.7] Enhanced thermoelectric performance of NbCoSb half-Heusler alloys by using an amorphous precursor SCIE 16.7 MATERIALS SCIENCE, CERAMICS;MATERIALS SCIENCE, MULTIDISCIPLINARY yish@knu.ac.kr;
Oh, Jeeyoung
(Oh, J)
Konkuk Univ, Med Ctr, Sch Med, Dept Neurol, Seoul, South Korea
0000-0002-0378-2947
OH, JEEYOUNG
[JCR상위 16.7] Clinical Usefulness of a Cell-based Assay for Detecting Myelin Oligodendrocyte Glycoprotein Antibodies in Central Nervous System Inflammatory Disorders SCIE 16.7 MEDICAL LABORATORY TECHNOLOGY juhongm@skku.edu;
Oh, Juwon
(Oh, J)
Soonchunhyang Univ, Dept Chem, Asan 31538, South Korea
0000-0003-0865-7595
Oh, Juwon
[JCR상위 16.7] Temperature Controlled Decay and Pendulum Dynamics of Green Fluorescent Protein (GFP) Chromophore SCIE 16.7 CHEMISTRY, PHYSICAL;MATERIALS SCIENCE, MULTIDISCIPLINARY;NANOSCIENCE & NANOTECHNOLOGY;PHYSICS, ATOMIC, MOLECULAR & CHEMICAL dongho@yonsei.ac.kr;cchoi@knu.ac.kr;
Oh, Sang Cheul
(Oh, SC)
Korea Univ, Guro Hosp, Dept Internal Med, Seoul, South Korea
Korea Univ Guro Hosp, Dept Internal Med, Seoul, South Korea


[JCR상위 16.7] Bemarituzumab plus mFOLFOX6 as first-line treatment in East Asian patients with FGFR2b-overexpressing locally advanced or metastatic gastric/gastroesophageal junction cancer: subgroup of FIGHT final analysis
[JCR상위 1.7] Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY
SCIE 1.7 GASTROENTEROLOGY & HEPATOLOGY;ONCOLOGY
ONCOLOGY
ykkang@amc.seoul.kr;
Oh, Sang Chul
(Oh, SC)
Korea Univ Guro Hosp, Seoul, South Korea

[JCR상위 16.7] Rivoceranib, a VEGFR-2 inhibitor, monotherapy in previously treated patients with advanced or metastatic gastric or gastroesophageal junction cancer (ANGEL study): an international, randomized, placebo-controlled, phase 3 trial SCIE 16.7 GASTROENTEROLOGY & HEPATOLOGY;ONCOLOGY ykkang@amc.seoul.kr;
Oh, Sei Yeul
(Oh, SY)
Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Ophthalmol, Seoul, South Korea

[JCR상위 16.7] Clinical Usefulness of a Cell-based Assay for Detecting Myelin Oligodendrocyte Glycoprotein Antibodies in Central Nervous System Inflammatory Disorders SCIE 16.7 MEDICAL LABORATORY TECHNOLOGY juhongm@skku.edu;
Park, Kyung-Ah
(Park, KA)
Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Ophthalmol, Seoul, South Korea

[JCR상위 16.7] Clinical Usefulness of a Cell-based Assay for Detecting Myelin Oligodendrocyte Glycoprotein Antibodies in Central Nervous System Inflammatory Disorders SCIE 16.7 MEDICAL LABORATORY TECHNOLOGY juhongm@skku.edu;
Park, Seong Yong
(Park, SY)
Kyungpook Natl Univ, Sch Med, Dept Microbiol, 680 Gukchaebosang Ro, Daegu 41944, South Korea

[JCR상위 16.7] Clonal Distribution and Its Association With the Carbapenem Resistance Mechanisms of Carbapenem-Non-Susceptible Pseudomonas aeruginosa Isolates From Korean Hospitals SCIE 16.7 MEDICAL LABORATORY TECHNOLOGY kimyg@knu.ac.kr;leejc@knu.ac.kr;
Park, Sin Hye
(Park, SH)
제1저자 Natl Canc Ctr, Ctr Gastr Canc, Ilsan Ro 323, Goyang Si 10408, South Korea
Catholic Univ Korea, Eunpyeong St Marys Hosp, Dept Surg, Seoul, South Korea


[JCR상위 16.7] Feasibility of intraoperative pathologic examination for sentinel lymph nodes during sentinel node navigation surgery in early gastric cancer: results of pathologic protocol for SENORITA trial SCIE 16.7 GASTROENTEROLOGY & HEPATOLOGY;ONCOLOGY mckook@ncc.re.kr;
Paul, Aritra
(Paul, A)
Heritage Inst Technol, Dept Biotechnol, Kolkata 700107, India

[JCR상위 16.7] Harnessing exosomes as cancer biomarkers in clinical oncology SCIE 16.7 ONCOLOGY krishnana1@ufs.ac.za;prakashg@knu.ac.kr;abc2000@knu.ac.kr;
Prasatkhetragarn, A.
(Prasatkhetragarn, A)
Univ Phayao, Sch Sci, Appl Sci Program, Phayao 56000, Thailand

[JCR상위 16.7] Synthesis and characterization of eco-friendly, stable green-emitting Tb 3+-doped borosilicate glasses using waste silica gel
[JCR상위 36.6] Green development of samarium borosilicate glasses doped silica gel waste for stable orange colored visible host material
[JCR상위 6.1] Synthesis of eco-friendly borosilicate glass with Eu³⁺ dopants: Harnessing recovered silica gel waste for reddish-orange emission materials
SCIE 6.1 MATERIALS SCIENCE, CERAMICS;MATERIALS SCIENCE, MULTIDISCIPLINARY
MATERIALS SCIENCE, MULTIDISCIPLINARY
CHEMISTRY, PHYSICAL;NUCLEAR SCIENCE & TECHNOLOGY;PHYSICS, ATOMIC, MOLECULAR & CHEMICAL
winzensio@gmail.com;pmanyum@sut.ac.th;jakrapong@webmail.npru.ac.th;
pmanyum@sut.ac.th;jakrapong@webmail.npru.ac.th;
winzensio@gmail.com;jakrapong@webmail.npru.ac.th;
Qin, Shukui
(Qin, SK)
China Pharmaceut Univ, Nanjing Tianyinshan Hosp, Affiliated Hosp 1, Nanjing, Peoples R China
Nanjing Univ Chinese Med, Jinling Hosp, Canc Ctr, Nanjing, Peoples R China
Jinling Hosp, Canc Ctr Nanjing, Nanjing, Peoples R China


[JCR상위 16.7] Bemarituzumab plus mFOLFOX6 as first-line treatment in East Asian patients with FGFR2b-overexpressing locally advanced or metastatic gastric/gastroesophageal junction cancer: subgroup of FIGHT final analysis
[JCR상위 1.7] EMERALD-1: A phase 3, randomized, placebo-controlled study of transarterial chemoembolization combined with durvalumab with or without bevacizumab in participants with unresectable hepatocellular carcinoma eligible for embolization.
[JCR상위 1.7] mRECIST outcomes in EMERALD-1: a phase 3, randomized, placebo-controlled study of transarterial chemoembolization plus durvalumab with/without bevacizumab in participants with embolization-eligible hepatocellular carcinoma
SCIE 1.7 GASTROENTEROLOGY & HEPATOLOGY;ONCOLOGY
ONCOLOGY
GASTROENTEROLOGY & HEPATOLOGY
ykkang@amc.seoul.kr;
bsangro@unav.es;
Rittisut, W.
(Rittisut, W)
제1저자 교신저자 Suranaree Univ Technol, Sch Phys, Nakhon Ratchasima 30000, Thailand
0000-0002-8781-6066
Rittisut, wipakorn
[JCR상위 16.7] Synthesis and characterization of eco-friendly, stable green-emitting Tb 3+-doped borosilicate glasses using waste silica gel
[JCR상위 36.6] Green development of samarium borosilicate glasses doped silica gel waste for stable orange colored visible host material
[JCR상위 6.1] Synthesis of eco-friendly borosilicate glass with Eu³⁺ dopants: Harnessing recovered silica gel waste for reddish-orange emission materials
SCIE 6.1 MATERIALS SCIENCE, CERAMICS;MATERIALS SCIENCE, MULTIDISCIPLINARY
MATERIALS SCIENCE, MULTIDISCIPLINARY
CHEMISTRY, PHYSICAL;NUCLEAR SCIENCE & TECHNOLOGY;PHYSICS, ATOMIC, MOLECULAR & CHEMICAL
winzensio@gmail.com;pmanyum@sut.ac.th;jakrapong@webmail.npru.ac.th;
pmanyum@sut.ac.th;jakrapong@webmail.npru.ac.th;
winzensio@gmail.com;jakrapong@webmail.npru.ac.th;
Rujirawat, S.
(Rujirawat, S)
Synchrotron Light Res Inst Publ Org, 111 Univ Ave, Nakhon Ratchasi 30000, Thailand
Synchrotron Light Res Inst, 111 Univ Ave, Nakhon Ratchasima 30000, Thailand
Publ Org, Synchrotron Light Res Inst, 111 Univ Ave, Nakhon Ratchasima 30000, Thailand


[JCR상위 16.7] Synthesis and characterization of eco-friendly, stable green-emitting Tb 3+-doped borosilicate glasses using waste silica gel
[JCR상위 36.6] Green development of samarium borosilicate glasses doped silica gel waste for stable orange colored visible host material
[JCR상위 6.1] Synthesis of eco-friendly borosilicate glass with Eu³⁺ dopants: Harnessing recovered silica gel waste for reddish-orange emission materials
SCIE 6.1 MATERIALS SCIENCE, CERAMICS;MATERIALS SCIENCE, MULTIDISCIPLINARY
MATERIALS SCIENCE, MULTIDISCIPLINARY
CHEMISTRY, PHYSICAL;NUCLEAR SCIENCE & TECHNOLOGY;PHYSICS, ATOMIC, MOLECULAR & CHEMICAL
winzensio@gmail.com;pmanyum@sut.ac.th;jakrapong@webmail.npru.ac.th;
pmanyum@sut.ac.th;jakrapong@webmail.npru.ac.th;
winzensio@gmail.com;jakrapong@webmail.npru.ac.th;
Ryu, Keun Won
(Ryu, KW)
Natl Canc Ctr, Ctr Gastr Canc, Ilsan Ro 323, Goyang Si 10408, South Korea
Natl Canc Ctr, Ctr Gastr Canc, Surg Dept, Goyang, South Korea


[JCR상위 16.7] Feasibility of intraoperative pathologic examination for sentinel lymph nodes during sentinel node navigation surgery in early gastric cancer: results of pathologic protocol for SENORITA trial
[JCR상위 1.0] Adjuvant nivolumab plus chemotherapy versus placebo plus chemotherapy for stage III gastric or gastro-oesophageal junction cancer after gastrectomy with D2 or more extensive lymph-node dissection (ATTRACTION-5): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial
SCIE 1.0 GASTROENTEROLOGY & HEPATOLOGY;ONCOLOGY
GASTROENTEROLOGY & HEPATOLOGY
mckook@ncc.re.kr;
msasako2010@yahoo.co.jp;
페이지 이동: